Green tea extract might help blood cancer clients
Izvor: KiWi
(Nova stranica: Green tea extract might help blood cancer clients <br /> <br />The individuals of the study were 4 victims of CLL, the most frequent kind of blood cancer, who were being offered drug…)
Trenutačna izmjena od 10:22, 2. veljače 2014.
Green tea extract might help blood cancer clients
The individuals of the study were 4 victims of CLL, the most frequent kind of blood cancer, who were being offered drugs containing green tea extract epigallocatechin gallate (EGCG). After a certain time period, a decline in cancerous cells in their bodies was discovered. 3 of the 4 patients indicated improved reaction to treatment and one had improved white blood cell count. One patient whose lymph nodes had swelled up up decreased in size after she began using green tea extract supplements.
Earlier in 2004, the same group of experts, led by Dr Tait Shanafelt, had performed a laboratory study of the effect of EGCG on leukemia cells. The studies were revealed in a 2004 version of the journal Blood. It had been found that the green tea extract killed the leukemia cells. In the event you claim to get further about website, there are tons of databases people might think about pursuing. The ability of those individuals gives some idea our previously published laboratory results could possibly translate into effects for patients with the disease, Dr Shanafelt said. Official Site contains more about the meaning behind this concept.
Green tea extract is definitely thought to have cancer-prevention features. It is interesting that research is now showing this agent may offer new expect CLL patients, Dr Shanafelt included. To date, no treatment is identified for CLL, a malignancy that always goals people over 55 years of age. According to Dr Shanafelt, further studies are necessary for establishing the precise process and influence and the amount of the extract that's perfect.
We don't know how many patients were taking similar items and failed to have any benefit. We also do not yet know the perfect amount that should be utilized, the fre-quency with which people should just take the medicine, and what negative effects is going to be seen with long-term administration, he explained. The hematologist is now developing an EGCG tablet for that US National Cancer Institute to learn whether the extract may be used-to treat patients with CLL.
The medical fraternity expressed optimism in the link between the study, but thought that it may be too soon to observe. Dig up additional info on this partner web resource by visiting address. The findings are interesting, but we can not say yet it is a new therapy for cancer. We must execute a sizable scale, controlled trial to determine if the results hold legitimate, said Ken Campbell of United Kingdoms Leukemia Research Fund. Around 7300 Americans are diagnosed with CLL annually, with men being more at the mercy of the illness than women.